SFN treatment was reported to decrease oxidants and to induce Nrf2 expression, antioxidants, and myofibroblast dedifferentiation in normal and IPF fibroblasts (Artaud-Macari et al., 2013). This evidence concerns the gene SFN and idiopathic interstitial pneumonia.